Inhibin at 90: from discovery to clinical application, a historical review - Wikidata - wikimedia - TriplyDB

Inhibin at 90: from discovery to clinical application, a historical review

Inhibin at 90: from discovery to clinical application, a historical review

http://www.wikidata.org/entity/Q34204531

about

Anti-Mullerian Hormone: Above and Beyond Conventional Ovarian Reserve Markers A Key Role for Inhibins in Dendritic Cell Maturation and Function.Activin/follistatin system in grass carp pituitary cells: - Regulation by local release of growth hormone and luteinizing hormone and its functional role in growth hormone synthesis and secretion.Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing.An Extra Arm May Impair the Open Hand.GATA4 and GATA6 Knockdown During Luteinization Inhibits Progesterone Production and Gonadotropin Responsiveness in the Corpus Luteum of Female Mice Timing in the Testis.Follicle Stimulating Hormone is an accurate predictor of azoospermia in childhood cancer survivors.Activins and Inhibins: Roles in Development, Physiology, and Disease.The role of TGF-β1 during skeletal muscle regeneration.Biological markers of fertility (inhibin-B) in HIV-infected men: influence of HIV infection and antiretroviral therapy.Prognostic value of follistatin-like 3 in human invasive breast cancer New hope for symptom management during natural and iatrogenic menopause transitions.Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.The molecular mechanism of ovarian granulosa cell tumors.The role of FSH and TGF-β superfamily in follicle atresia.From Consternation to Revelation: Discovery of a Role for IGSF1 in Pituitary Control of Thyroid Function.Fshb Knockout Mouse Model, Two Decades Later and Into the Future.

P2860

Q26765770-AA41D27B-7571-427B-BABA-821EF5AAFC03 Q30367244-C10F9B9E-AAD0-43E4-A322-062458CB306A Q33853064-A15F8A85-3419-4B1D-9AFF-6A55991CAB5F Q35786468-4A543942-45AF-438A-BD73-C2DF0C55D033 Q35878808-517FF444-D539-4354-82AB-8EF54ECFC3D9 Q36461983-53CEF327-7EE8-41E5-AEED-24B03DFF65BB Q38666224-789CC151-FEAF-439D-8B6D-ECBEC55CE46B Q38669965-B514DA13-1F5C-4596-BE68-522A926DDCFB Q38872337-55C4829F-5C16-4857-9A7C-73B3897FD0D2 Q39062904-4EEC0084-0FA0-487A-BEA5-03DA78778C9F Q40863813-085A40D2-54ED-42C4-92AE-482782C2F83F Q41091935-5653985C-09C9-4A28-B420-F6A195170E95 Q47566998-95AC7BA1-8BE1-45D3-B174-BE887288D6B6 Q50104995-AC41EC01-476C-4469-8EBE-4E7C0FA50631 Q50156697-CCDA4CB8-7406-4857-A369-43B94EF18BDD Q51766047-A537852F-9471-4272-9F34-48BB68F707AD Q52624050-D89A2FA6-90D2-4B2C-87E6-41D698BF8228 Q52724092-9D86A3F1-BCD8-4CF4-9A9B-0B8BC64F6FB2

P2860

Inhibin at 90: from discovery to clinical application, a historical review

http://www.wikidata.org/entity/Q34204531

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Inhibin at 90: from discovery to clinical application, a historical review

@ast

Inhibin at 90: from discovery to clinical application, a historical review

@en

Inhibin at 90: from discovery to clinical application, a historical review

@nl

type

label

Inhibin at 90: from discovery to clinical application, a historical review

@ast

Inhibin at 90: from discovery to clinical application, a historical review

@en

Inhibin at 90: from discovery to clinical application, a historical review

@nl

prefLabel

Inhibin at 90: from discovery to clinical application, a historical review

@ast

Inhibin at 90: from discovery to clinical application, a historical review

@en

Inhibin at 90: from discovery to clinical application, a historical review

@nl

P1433

Q34204531-FEAC7F5D-2AFB-4939-A3DB-CD1EFED74CBA

P1476

Q34204531-41922EB3-3D5E-499B-A2E9-1F28DCD737F3

P2093

Q34204531-00FA7B47-B8E0-4AAD-AC88-8711A10ECAD5

Q34204531-11DF8D6B-A484-4CEF-9D26-35D2A5B0DB00

Q34204531-63A8E353-0014-4469-8ADC-26C35A5B8AFB

Q34204531-669CF4FA-CFD3-496B-9C3D-F36C2535ADA4

Q34204531-A7832E7E-C32D-4751-8227-199C0B473E0A

Q34204531-AC3D18EF-5509-4DFF-8C2B-A412C9898874

Q34204531-CB759498-FA16-469F-A6EA-99AA12680FD0

P2860

Q34204531-00BA4272-FFAC-4AFE-97AD-7627212828A1

Q34204531-00BB6DD4-14CA-4A25-B130-3DAB0C3A55FE

Q34204531-01309216-1C4A-4013-B55C-F8C9EC78BA12

Q34204531-018810C9-E36B-4E59-98A9-5FAEC7394786

Q34204531-02933A82-5F45-49B4-B07E-3E0ABDE4EDBA

Q34204531-02FAE24A-9049-4AE0-8600-272B3C17ECB9

Q34204531-032C9B00-F233-4DB9-9E85-EA575AFCAC74

Q34204531-038C9284-33E4-45C2-842B-155E37993FF4

Q34204531-0476C056-222E-480A-8909-3CD2ADEC6211

Q34204531-04D96384-5C11-4033-9A1E-C16CDE097F5D

P304

Q34204531-4B24D793-F2D2-4D6C-BB2F-9AC3E4513425

P31

Q34204531-AEA32F92-B765-4EA5-A43F-7E0AC3F45F9E

P356

Q34204531-29F61B40-05D0-4C55-9A5F-65DAF1D5CD96

P433

Q34204531-9820CFA6-2880-4A5C-9634-DBF09E385752

P478

Q34204531-BBECD011-E716-41E7-9D1E-1D685DB9F70B

P50

Q34204531-2AB7505A-06A5-41BF-A35B-D5FC1AAA70A4

P577

Q34204531-A3085565-4DAF-44DF-9179-11A012143249

P5875

Q34204531-E7D8E5B4-9999-4525-A2E2-C3E0C1418C08

P698

Q34204531-E3649672-0403-4AC4-8A84-3450712F27F0

P932

Q34204531-C933E406-4EDB-4733-84ED-AD5172208C50

P356

P1433

Endocrine Reviews

P1476

Inhibin at 90: from discovery to clinical application, a historical review

@en

P2093

Chris Holmquist

http://www.w3.org/2001/XMLSchema#string

Jie Zhu

http://www.w3.org/2001/XMLSchema#string

Kelly E Mayo

http://www.w3.org/2001/XMLSchema#string

Neena B Schwartz

http://www.w3.org/2001/XMLSchema#string

Rama Mishra

http://www.w3.org/2001/XMLSchema#string

Winifred P S Wong

http://www.w3.org/2001/XMLSchema#string

Yogeshwar Makanji

http://www.w3.org/2001/XMLSchema#string

P2860

Betaglycan binds inhibin and can mediate functional antagonism of activin signalling

Crystal structure of the BMP-2-BRIA ectodomain complex

Insertion of Inhbb into the Inhba locus rescues the Inhba-null phenotype and reveals new activin functions

Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP)

Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development

Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin beta A chain

Identification of a functional binding site for activin on the type I receptor ALK4

Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG)

Structural basis for the inhibition of activin signalling by follistatin.

Expression of activin subunits and receptors in the developing human ovary: activin A promotes germ cell survival and proliferation before primordial follicle formation

P304

747-794

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/ER.2014-1003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Teresa K. Woodruff

P577

2014-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264127595

http://www.w3.org/2001/XMLSchema#string

P698

25051334

http://www.w3.org/2001/XMLSchema#string

P932

4167436

http://www.w3.org/2001/XMLSchema#string